DCRT's Annemieke Aartsma-Rus, Willeke van Roon-Mom and Alex Garanto wrote the Consensus Guidelines for the Design and In Vitro Preclinical Efficacy Testing N-of-1 Exon Skipping Antisense Oligonucleotides together with other members of the N=1 Collaborative.
Let us know your questions or suggestions